1.17

2.63% 0.03

After Hours: 1.22 0.05 +4.27%

Allarity Therapeutics Inc (ALLR)

Overview News Price History Financials Discussions Forecast Stock Split

Allarity Therapeutics Inc stock is traded at $1.17, with a volume of 279.02K. It is up +2.63% in the last 24 hours and down -4.10% over the past month. Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Previous Close:

$1.14

Open:

$1.14

24h Volume:

279.02K

Relative Volume:

0.76

Market Cap:

$18.49M

Revenue:

Net Income/Loss:

$-11.90M

P/E Ratio:

-0.00568

EPS:

-206.0125

Net Cash Flow:

$-12.75M

1W Performance:

+7.34%

1M Performance:

-4.10%

6M Performance:

+28.71%

1Y Performance:

+14.71%

1-Day Range:

$1.12

$1.22

1-Week Range:

$1.08

$1.22

52-Week Range:

$0.6138

$2.35

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Name

Allarity Therapeutics Inc

Sector

Healthcare (1124)

Industry

Biotechnology (627)

Phone

401-426-4664

Address

24 SCHOOL ST., 2ND FLOOR, BOSTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ALLR's Discussions on Twitter

Compare ALLR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALLR Allarity Therapeutics Inc	1.17	18.01M	0	-11.90M	-12.75M	-206.01
VRTX Vertex Pharmaceuticals Inc	444.64	110.88B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	726.21	72.79B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	890.11	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	404.46	54.85B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	189.85	41.41B	447.02M	-1.18B	-906.14M	-6.1812

Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-28-25	Initiated	Ascendiant Capital Markets	Buy

Allarity Therapeutics Inc Stock (ALLR) Latest News

Dec 09, 2025

Ascendiant Capital Maintains Allarity Therapeutics (ALLR) Buy Recommendation - Nasdaq

Dec 09, 2025

ALLR: Ascendiant Capital Raises Price Target, Maintains Buy Rating | ALLR Stock News - GuruFocus

Dec 09, 2025

Dec 08, 2025

Allarity Therapeutics updates CFO employment agreement with full-time terms By Investing.com - Investing.com Australia

Dec 08, 2025

Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO - TipRanks

Dec 08, 2025

Allarity Therapeutics updates CFO employment agreement with full-time terms - Investing.com

Dec 08, 2025

Dec 04, 2025

Will Allarity Therapeutics Inc. stock benefit from sector rotationTrade Exit Summary & Trade Opportunity Analysis - Newser

Dec 04, 2025

Will Allarity Therapeutics Inc. stock return to pre crisis levelsPortfolio Update Report & High Yield Stock Recommendations - Newser

Dec 04, 2025

Can Allarity Therapeutics Inc. stock continue upward trendJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser

Dec 04, 2025

Dec 03, 2025

Allarity Therapeutics Inc to offer up to $50 million in securities - marketscreener.com

Dec 03, 2025

Nov 30, 2025

How Allarity Therapeutics Inc. stock trades before earningsJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ

Nov 30, 2025

Nov 27, 2025

Published on: 2025-11-28 11:27:30 - moha.gov.vn

Nov 27, 2025

Is Allarity Therapeutics Inc. stock a buy before product launchesJuly 2025 Sector Moves & Fast Gaining Stock Reports - BỘ NỘI VỤ

Nov 27, 2025

A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews

Nov 27, 2025

Nov 26, 2025